Association between liver vitamin A reserves and severity of nonalcoholic fatty liver disease in the class III Obese following bariatric surgery

Obesity Surgery

Volumn 24, Issue 2, 2014, Pages 219-224

  Chaves, Gabriela Villaça ^a,c   Pereira, Sílvia Elaine ^a   Saboya, Carlos José ^a   Spitz, Daiane ^a   Rodrigues, Camila Santos ^b   Ramalho, Andréa ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^c Rua General Ribeiro da Costa   (Brazil)

Author keywords

Nonalcoholic fatty liver disease; Oxidative stress; Vitamin A

Indexed keywords

RETINOL;

ADULT; ARTICLE; BARIATRIC SURGERY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIVER BIOPSY; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; NUTRITIONAL STATUS; OBESITY; PRIORITY JOURNAL; RETINOL DEFICIENCY; VITAMIN BLOOD LEVEL;

ADULT; BARIATRIC SURGERY; BIOLOGICAL MARKERS; BODY MASS INDEX; CROSS-OVER STUDIES; DISEASE PROGRESSION; FATTY LIVER; FEMALE; HUMANS; LIVER; MALE; NUTRITIONAL STATUS; OBESITY, MORBID; SEVERITY OF ILLNESS INDEX; SOCIAL CLASS; VITAMIN A; VITAMIN A DEFICIENCY;

EID: 84893041833     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-013-1087-8     Document Type: Article

References (27)

1. Festi D, Colecchia A, Sacco T, et al. Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes Rev. 2004;5(1):27-42.
2. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology. 1998;114:842-5.
3. Chaves GV, Pereira SE, Saboya CJ, et al. Non-alcoholic fatty liver disease and its relationship with nutritional status of vitamin A in individuals with class III obesity. Obes Surg. 2008;18:378-85.
4. Park SK, Lee HJ, Lee DH, et al. Associations of non alcoholic fatty liver disease with the metabolic syndrome and serum carotenoids. J Prev Med Public Health. 2008;41:39-44.
5. Yadav D, Hertan HI, Schweitzer P, et al. Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C. Am J Gastroenterol. 2002;97:2634-9.
6. Friedman LS. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008;88:125-72.
7. Shirakami Y, Gottesman ME, Blaner WS. Diethylnitrosamine-induced hepatocarcinogenesis is suppressed in lecithin:retinol acyltransferase-deficient mice primarily through retinoid actions immediately after carcinogen administration. Carcinogenesis. 2012;33(2):268-74.
8. Cuppari L. Guias de Medicina Ambulatorial e Hospitalar. Nutrição Clínica no Adulto. UNIFESP. São Paulo: Manole, 2002
9. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. WHO: Geneva, 1998
10. World Health Organization. Indicators for assessing vitamin A deficiency and their application in monitoring and evaluating intervention programmes. Micronutrient Series, WHO/NUT. 10. World Health Organization, Geneva, Switzerland, 1996
11. IVACG (International Vitamin A Consultative Group). Improving the vitamin A status of populations. USAID-ILSI. 2003
12. Flores H, Ramalho RA, Ribeiro AR. Intrahepatic distribution of vitamin A in humans and rats. Int J Vit Nutr Res. 1988;58(3):276-80.
13. Araujo CR, Flores H. Improved spectrophotometric vitamin A assay. Clin Chem. 1978;24(2):386.
14. Arroyave G, Chichester CO. Biochemical methodology for the assessment of vitamin A status: a report of International Vitamin A Consultative Group. The Nutrition Foundation: Washington; 1982.
15. Olson JA, Gunning D, Tilton R. The distribution of vitamin A in human liver. Am J Clin Nutr. 1979;32(12):2500-7.
16. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94(9):2467-74.
17. Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2007;25:883-9.
18. Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006;40:s5-s10.
19. Peres WA, Chaves GV, Gonçalves JCS, et al. Vitamin A deficiency in patients with hepatitis C virus-related chronic liver disease. British J Nutr. 2011;6(11):1724-31.
20. Paula TP, Ramalho A, Braulio VB. The effectiveness of relative dose response to retinol intake as an evaluation of vitamin A status of cirrhotic patients. J Hum Nutr Diet. 2010;23(6):583-9.
21. Clemente C, Elba S, Buongiorno G, et al. Serum retinol and risk of hepatocellular carcinoma in patients with Child-Pugh class A cirrhosis. Cancer Lett. 2002;178:123-9.
22. Tanumihardjo SA. Vitamin A: biomarkers of nutrition development. Am J Clin Nutr. 2011;94:658S-65S.
23. IOM (Institute of Medicine). Food and nutrition board. Vitamin A. In: Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, vanadium, manganese, molybdenum, nickel, silicon, vanadium and zinc. Washington: National Academy Press; 2001. pp. 82-161.
24. Musso G, Gambino R, De Micheli F, et al. Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake. Am J Clin Nutr. 2007;86:661-71.
25. Sugiura M, Nakamura M, Ikoma Y, et al. The homeostasis model assessment-insulin resistance index is inversely associated with serum carotenoids in non-diabetic subjects. J Epidemiol. 2006;16:71-8.
26. Ashla AF, Hoshikawa Y, Tsuchiya H, et al. Genetic analysis of expression profile involved in retinoid metabolism in non-alcoholic fatty liver disease. Hepatol Res. 2010;40:594-604.
27. Amengual J, Ribot J, Bonet L, et al. Retinoic acid treatment enhances lipid oxidation and inhibits lipid biosynthesis capacities in the liver of mice. Cell Physiol Biochem. 2010;25:657-66.